Evidence map›Paper›PMID 33947766›Full record

ArticlemBio2021

The Zinc Finger Antiviral Protein ZAP Restricts Human Cytomegalovirus and Selectively Binds and Destabilizes Viral

Ana Cristina Gonzalez-Perez, Markus Stempel, Emanuel Wyler, Christian Urban, Antonio Piras, Thomas Hennig, Sabina Ganskih, Yuanjie Wei, Albert Heim, Markus Landthaler and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. The Autophagy ReceptorViruses · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Ana Cristina Gonzalez-PerezViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0002-8674-1525
Markus StempelViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0002-9240-3987
Emanuel WylerBerlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Christian UrbanSchool of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
Antonio PirasSchool of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
Thomas HennigInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID 0000-0002-7788-1681
Sabina GanskihHelmholtz-Institute for RNA-based Infection Research, HIRI, Würzburg, Germany.
Yuanjie WeiHelmholtz-Institute for RNA-based Infection Research, HIRI, Würzburg, Germany.
Albert HeimInstitute of Virology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-9447-1561
Markus LandthalerBerlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Andreas PichlmairSchool of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
Lars DölkenInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Mathias MunschauerHelmholtz-Institute for RNA-based Infection Research, HIRI, Würzburg, Germany.
Florian ErhardInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Melanie M BrinkmannViral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany m.brinkmann@tu-braunschweig.de.ORCID 0000-0001-5431-6527
Helmholtz Centre for Infection Research · DEHelmholtz Institute for RNA-based Infection Research · DETechnical University of Munich · DEUniversity of Würzburg · DEMax Delbrück Center · DEMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon-stimulated gene products (ISGs) play a crucial role in early infection control. The ISG zinc finger CCCH-type antiviral protein 1 (ZAP/ZC3HAV1) antagonizes several RNA viruses by binding to CG-rich RNA sequences, whereas its effect on DNA viruses is less well understood. Here, we decipher the role of ZAP in the context of human cytomegalovirus (HCMV) infection, a β-herpesvirus that is associated with high morbidity in immunosuppressed individuals and newborns. We show that expression of the two major isoforms of ZAP, ZAP-S and ZAP-L, is induced during HCMV infection and that both negatively affect HCMV replication. Transcriptome and proteome analyses demonstrated that the expression of ZAP results in reduced viral mRNA and protein levels and decelerates the progression of HCMV infection. Metabolic RNA labeling combined with high-throughput sequencing (SLAM-seq) revealed that most of the gene expression changes late in infection result from the general attenuation of HCMV. Furthermore, at early stages of infection, ZAP restricts HCMV by destabilizing a distinct subset of viral mRNAs, particularly those from the previously uncharacterized

Indexed as

Cell LineCells, CulturedCytomegalovirusFibroblastsHEK293 CellsHost Microbial InteractionsHumansProtein IsoformsRNA-Binding ProteinsViral Envelope ProteinsViral ProteinsVirus ReplicationProtein IsoformsRNA-Binding ProteinsUL4 protein, Human cytomegalovirusViral Envelope ProteinsViral ProteinsZC3HAV1 protein, humanantiviralDNA virusHCMVherpesvirushuman cytomegalovirusinnate immunityinterferonsISGmRNA degradationpattern recognition receptorsZAPZC3HAV1zinc finger proteins

Identifiers

PMID33947766
PMCPMC8263000
OpenAlexW3158996207

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.